Detail akcie Sol-Gel Tech Rg online

Business Summary: Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Sol Gel Technologies Ltd revenues increased from $1.6M to $11.5M. Net loss decreased 61% to $10.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research & Development Expense decrease of 25% to $17.5M (expense), General & Administrative Expenses decrease of 22% to $5.2M (expense).